Asked by: Kim Johnson (Labour - Liverpool Riverside)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of access to peer support services for people living with HIV.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is committed to ending new transmissions of HIV in England by 2030 and is developing the new HIV Action Plan, which we aim to publish this year. The plan will address ways to optimise rapid access to treatment and retention in care, and will improve the quality of life for people living with HIV, including consideration of peer support services.
A key component of the Government’s successful HIV emergency department opt-out testing programme includes a recommendation that 10% of the funding allocated to each site should be used to support community and peer services for individuals diagnosed with a blood borne virus.
NHS England is responsible for delivering HIV care, including support services for those living with HIV. In April 2024, it published the updated national Service Specification for Adult HIV services, which sets out the standards of care that HIV providers are expected to meet, including the availability of community, psychological, and psychosocial support for patients.
Asked by: Liz Jarvis (Liberal Democrat - Eastleigh)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to improve access to HIV support services for people affected by HIV.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is committed to ending new transmissions of HIV in England by 2030 and is developing the new HIV Action Plan, which we aim to publish this year. The plan will address ways to optimise rapid access to treatment and retention in care, and will improve the quality of life for people living with HIV, including consideration of peer support services.
A key component of the Government’s successful HIV emergency department opt-out testing programme includes a recommendation that 10% of the funding allocated to each site should be used to support community and peer services for individuals diagnosed with a blood borne virus.
NHS England is responsible for delivering HIV care, including support services for those living with HIV. In April 2024, it published the updated national Service Specification for Adult HIV services, which sets out the standards of care that HIV providers are expected to meet, including the availability of community, psychological, and psychosocial support for patients.
Asked by: Andrew Rosindell (Conservative - Romford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what comparative assessment he has made of trends in the level of late diagnosis of (a) blood cancers and (b) solid tumour cancers.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
There are no current plans to introduce a specific proxy staging measure or a corresponding national target to support the earlier diagnosis of blood cancers. To tackle late diagnoses of blood cancers, the National Health Service is implementing non-specific symptom pathways for patients who present with symptoms such as weight loss and fatigue, which do not clearly align to a tumour type. Blood cancers are one of the most common cancer types diagnosed through these pathways.
It is a priority for the Government to support the National Health Service to diagnose cancer, including blood cancer, as early and quickly as possible, and to treat it faster, to improve outcomes. We will get the NHS diagnosing blood cancer earlier and treating it faster, and we will support the NHS to increase capacity to meet the demand for diagnostic services through investment, including for magnetic resonance imaging and computed tomography scanners.
The National Cancer Plan will include further details on how we will improve outcomes for cancer patients, including those with blood cancer and other cancers with lower survival rates.
Asked by: Brian Mathew (Liberal Democrat - Melksham and Devizes)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of a national register of defibrillators.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Circuit is the independently operated national automated external defibrillator databased, developed by a partnership of the British Heart Foundation, the National Health Service, the Resuscitation Council UK, and the Association of Ambulance Chief Executives. The Circuit provides a national database of where defibrillators can be found so that ambulance services can quickly identify the nearest defibrillator.
There are now over 100,000 defibrillators in the United Kingdom registered on The Circuit. There are no plans to establish a separate national register.
Asked by: Liz Jarvis (Liberal Democrat - Eastleigh)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he has conducted an impact assessment for the decision to extend cervical screening intervals.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The UK National Screening Committee’s recommendation to change the cervical screening intervals from three to five years for women aged 25 to 49 years old was made in 2019. The evidence and consultation responses supporting the recommendation can be found at the following link:
https://view-health-screening-recommendations.service.gov.uk/cervical-cancer/
The decision to make the changes was based on what is best for individuals. The more accurate human papillomavirus test requires less frequent screening, and changing the frequency eliminates the unnecessary over screening of the population.
The IT system supporting the national cervical screening programme was updated in July 2024, and can now enable the changes that were recommended.
A full impact assessment and equality impact assessment were considered before the changes were agreed by the Government. We will publish these shortly.
Asked by: Cat Smith (Labour - Lancaster and Wyre)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure that disabled children with a diagnosis of Foetal Valproate Syndrome between the ages of 16yrs old and 18 yrs old receive the full amount of care which was given during their paediatric years.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
Everyone who has been harmed by sodium valproate has our deepest sympathies.
NHS England recognises that healthcare transition should be need and complexity based, not managed solely on diagnosis or what is routinely provided. Its Children and Young People’s Transformation Programme, along with key stakeholders, has developed a framework to aid the design of healthcare transition pathways that reduce health inequalities and improve health outcomes for all young people.
The guidance outlines key principles and examples of models of care for those aged between zero and 25 years old, including clearer accountability and improved services for those aged 16 to 17 years old. NHS England is due to publish this guidance later this summer.
Asked by: Cat Smith (Labour - Lancaster and Wyre)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that disabled children between the ages of 16 and 18 with a diagnosis of foetal valproate syndrome receive the full amount of care that was provided during their paediatric years.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
Everyone who has been harmed by sodium valproate has our deepest sympathies.
NHS England recognises that healthcare transition should be need and complexity based, not managed solely on diagnosis or what is routinely provided. Its Children and Young People’s Transformation Programme, along with key stakeholders, has developed a framework to aid the design of healthcare transition pathways that reduce health inequalities and improve health outcomes for all young people.
The guidance outlines key principles and examples of models of care for those aged between zero and 25 years old, including clearer accountability and improved services for those aged 16 to 17 years old. NHS England is due to publish this guidance later this summer.
Asked by: Cat Smith (Labour - Lancaster and Wyre)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the oral contribution of the Parliamentary Under-Secretary of State for Health and Social Care in the debate of 27 March 2025 on Hughes Report: First Anniversary, Official Report, column 472WH, what his planned timetable is for considering the costs of the Patient Safety Commissioner's report on valproate.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is carefully considering the work by the Patient Safety Commissioner and her report, which set out options for redress for those harmed by valproate and pelvic mesh. This is a complex issue involving input from different Government departments. The Government will provide a further update to the Patient Safety Commissioner’s report.
Asked by: Cat Smith (Labour - Lancaster and Wyre)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department has met with Sanofi to discuss the topic of redress for people affected by Sodium Valproate in pregnancy since July 2024.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is carefully considering the work by the Patient Safety Commissioner and her report, which set out options for redress for those harmed by valproate and pelvic mesh. This is a complex issue involving input from different Government departments. The Government will provide a further update to the Patient Safety Commissioner’s report.
Asked by: Cat Smith (Labour - Lancaster and Wyre)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what estimate he has made of the number of potential claimants for redress for valproate.
Answered by Ashley Dalton - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is carefully considering the work by the Patient Safety Commissioner and her report, which set out options for redress for those harmed by valproate and pelvic mesh. This is a complex issue involving input from different Government departments. The Government will provide a further update to the Patient Safety Commissioner’s report.